Skip to main content

and
  1. No Access

    Protocol

    Salmonella Phages and Prophages: Genomics, Taxonomy, and Applied Aspects

    Since this book was originally published in 2007 there has been a significant increase in the number of Salmonella bacteriophages, particularly lytic virus, and Salmonella strains which have been fully sequenc...

    Andrea I. Moreno Switt, Alexander Sulakvelidze, Martin Wiedmann in Salmonella (2015)

  2. No Access

    Protocol

    Targeting Brain Tumor Stem Cells with Oncolytic Adenoviruses

    In 2004, brain tumor stem cells (BTSCs) were isolated from surgical human malignant gliomas. This cancer cell population has been identified as the root for tumor initiation and resistance to therapies. Thus, ...

    Marta M. Alonso, Hong Jiang, Candelaria Gomez-Manzano, Juan Fueyo in Oncolytic Viruses (2012)

  3. No Access

    Protocol

    Construction of Targeted and Armed Oncolytic Adenoviruses

    Oncolytic (replication-competent) adenoviruses (Ads) represent the most advanced platform for cancer gene therapy. These viral vectors ablate tumors by killing tumor cells in the process of virus replication. ...

    Konstantin Doronin, Dmitry M. Shayakhmetov in Oncolytic Viruses (2012)

  4. No Access

    Protocol

    The Development of Gene Therapy: From Monogenic Recessive Disorders to Complex Diseases Such as Cancer

    During the last 4 decades, gene therapy has moved from preclinical to clinical studies for many diseases ranging from monogenic recessive disorders such as hemophilia to more complex diseases such as cancer, c...

    Jean-Pierre Gillet, Benjamin Macadangdang, Robert L. Fathke in Gene Therapy of Cancer (2009)

  5. No Access

    Protocol

    A Real-Time Taqman® Method for Hepatitis C Virus Genoty** and Methods for Further Subty** of Isolates

    The HCV genome is highly heterogeneous; more and more genotypes, each with several distinct subtypes, are being identified around the world. Knowledge of genotype is important for planning of treatment regimes...

    Kathryn J. Rolfe, Tim G. Wreghitt, Graeme J. M. Alexander, Martin D. Curran in Hepatitis C (2009)

  6. No Access

    Protocol

    Selection and Characterization of Drug-Resistant HCV Replicons In Vitro with a Flow Cytometry-Based Assay

    Because HCV RNA-dependent RNA polymerase is error-prone and the viral RNA has a high turnover rate, the genetic diversity of HCV is very high both in vitro and in vivo. The mutation rate in long-term replicon cul...

    Jason M. Robotham, Heather B. Nelson, Hengli Tang in Hepatitis C (2009)

  7. No Access

    Protocol

    In Vivo Study of HCV in Mice with Chimeric Human Livers

    Estimates of hepatitis C virus infection include 170 million people worldwide, who face increased risk of development of cirrhosis, liver failure, and hepatocellular carcinoma. Standard of care therapy with pe...

    Norman M. Kneteman, Christian Toso in Hepatitis C (2009)

  8. No Access

    Protocol

    Cellular Receptors and HCV Entry

    After attachment to specific receptors on the surfaces of target cells, hepatitis C virus (HCV) particles are thought to be internalized to endosomes, where low pH induces fusion between the viral and cellular...

    Mike Flint, Donna M. Tscherne in Hepatitis C (2009)

  9. No Access

    Protocol

    Magnetic Resonance Microscopy of Mouse Brain Development

    Magnetic resonance imaging (MRI) is increasingly becoming an important tool to study anatomy of rodent brains. Compared with histology, it has clear advantages because the entire 3D object can be captured as a...

    Susumu Mori, Jiangyang Zhang, Jeff W. M. Bulte in Magnetic Resonance Imaging (2006)

  10. No Access

    Protocol

    Construction of VNP20009

    The engineering of tumor-targeting Salmonella strains bearing a high degree of both attenuation and tumor inhibition is a recently developed approach to vector-based treatment of cancer (1,2). Tumor-targeted Salm...

    Kenneth Brooks Low, Martina Ittensohn, **ang Luo, Li-Mou Zheng in Suicide Gene Therapy (2004)

  11. No Access

    Protocol

    Chronic Intracerebral Delivery of Trophic Factors via a Programmable Pump as a Treatment for Parkinsonism

    The most common treatment for Parkinson’s disease (PD) aims at pharmacologically augmenting striatal dopamine (DA) using the DA precursor levodopa. Such treatment provides symptomatic relief, but does not slow...

    Richard Grondin, Zhiming Zhang, Dennis D. Elsberry, Greg A. Gerhardt in Parkinson's Disease (2001)

  12. No Access

    Protocol

    Intraocular Delivery of Recombinant Virus

    In the past 5 yr, advances in technology have been made that allow efficient somatic transfer of functional genes to target cells in the eye in vivo. The ability to deliver functional genes to these cells is d...

    Fong-Qi Liang, Vibha Anand, Albert M. Maguire, Jean Bennett in Vision Research Protocols (2001)